Vaccinex, Inc. (VCNX) Total liabilities 2017–2024
Vaccinex, Inc. (VCNX) total liabilities at each fiscal year-end, per SEC filings.
$5.1MFY2024 · since FY2017: $7.3M → $5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $5.1M | -14.4% |
| FY2023 | $5.9M | +113.4% |
| FY2022 | $2.8M | +14.5% |
| FY2021 | $2.4M | -83.0% |
| FY2020 | $14.3M | +108.1% |
| FY2019 | $6.9M | +2.9% |
| FY2018 | $6.7M | -9.0% |
| FY2017 | $7.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More VCNX financial trends
VCNX RevenueVCNX Net incomeVCNX Net marginVCNX Gross profitVCNX Gross marginVCNX Operating incomeVCNX Operating marginVCNX Operating cash flowVCNX Free cash flowVCNX Capital expendituresVCNX Return on equityVCNX Stock buybacksVCNX Dividends paidVCNX Total assetsVCNX Shareholders’ equityVCNX overview →